UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

                        Pursuant to Section 13 OR 15(d)
                  of the Securities and Exchange Act of 1934


                                  June 15, 2004
                               ------------------
                                 Date of Report



                              ENVIROKARE TECH INC
             ------------------------------------------------------
             (Exact Name of Registrant as Specified in its Charter)



                                     Nevada
                 ----------------------------------------------
                 (State or Other Jurisdiction of Incorporation)



       000-26095                                           88-0412549
- -----------------------                        ---------------------------------
(Commission File Number                        (IRS Employer Identification No.)



             5850 T.G. Lee Blvd, Suite 535, Orlando, Florida 89120
             ------------------------------------------------------
               (address of Principal Executive Offices)(Zip Code)


                                 (407) 856-8882
              ----------------------------------------------------
              (Registrant's Telephone Number, Including Area Code)


                                 Not Applicable
         -------------------------------------------------------------
         (Former Name or Former Address, if Changed since last Report)






Item 5. Other Events and Regulation FD Disclosure


     1. Exclusivity  Agreement with NOVA Chemicals Inc.,  (hereinafter "NOVA") .
Envirokare  Tech,  Inc. (ENVK) ( hereinafter  "Envirokare")  has entered into an
Exclusivity  Agreement with NOVA dated June 1, 2004 which generally  states that
until August 31, 2004, Envirokare will not undertake, encourage or institute any
proposed  transaction  related to the use,  license or sublicense of the TPF(tm)
technology (the  "technology") with other companies except as otherwise provided
in that  agreement  and  will  exclusively  negotiate  with  NOVA to  secure  an
agreement  for  such  use,  license  and  sublicense  of  the  technology.   The
Exclusivity Agreement in its entirety is filed herewith as Exhibit 10.26.

     In Exchange for this Agreement and the Warrant  Agreement  described below,
Nova has paid to Envirokare the sum of $250,000.00.

     As part of this  transaction,  Envirokare has issued to NOVA a Common Stock
Purchase  Warrant dated June 1, 2004 which  entitles Nova to purchase  1,250,000
shares of Envirokare  common stock at a price of $.20 per share until June 2014.
In the event that  Envirokare  and NOVA enter into a definitive  agreement for a
transaction,  NOVA will receive $250,000 in Envirokare common shares at the then
market price. In that event, the Common Stock Purchase Warrant  referenced above
will at the option of Envirokare be cancelled. The Common Stock Purchase Warrant
in its entirety is filed herewith as Exhibit 10.27.




c) Exhibits

Exhibit No.         Description of Document
- ----------          ------------------------
10.26               Exclusivity Agreement with NOVA Chemicals Inc.
10.27               Common Stock Purchase Warrant




                                   SIGNATURE

Pursuant to the  requirements  of the  Securities  and Exchange Act of 1934, the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.


Date:  June 15, 2004                   Envirokare Tech Inc


                                        /s/ George Kazantzis
                                        ------------------------------
                                        George Kazantzis, CEO